nsclc Clinical Trials and Research
Also known as: non-small cell lung cancer, lung adenocarcinoma, squamous cell lung carcinoma, large cell carcinoma, nsclc lung cancer · ICD-10: C34.9
Non-Small Cell Lung Cancer (NSCLC) is the most common form of lung cancer. Clinical trial research is actively exploring new targeted therapies, immunotherapies, and combination treatments to improve patient outcomes and survival. Find a Trial helps patients search for active studies in this area.
Common questions about nsclc clinical trials
Who can participate in NSCLC clinical trials?
Eligibility criteria vary by study, often including factors like cancer stage, previous treatments, and overall health. Researchers use these criteria to ensure patient safety and collect relevant data, as seen on ClinicalTrials.gov.
What are the different phases of NSCLC clinical trials?
NSCLC clinical trials progress through phases 1, 2, and 3. Phase 1 studies assess safety, phase 2 evaluates effectiveness, and phase 3 compares new treatments to standard care, according to data from ClinicalTrials.gov.
What are current research directions for NSCLC?
Current NSCLC research focuses on precision medicine, including targeted therapies for specific genetic mutations, and novel immunotherapies that boost the body's immune response. Studies also explore combination treatments, as documented on NIH RePORTER.
What types of interventions are studied in NSCLC trials?
NSCLC trials investigate various interventions, such as new chemotherapy drugs, targeted therapies that block cancer growth, immunotherapies, and radiation techniques. Surgical approaches and supportive care strategies are also explored, per ClinicalTrials.gov.
Are there specific biomarkers important in NSCLC clinical trials?
Yes, biomarkers like EGFR mutations, ALK rearrangements, and PD-L1 expression are crucial in NSCLC trials. These markers help identify patients who may respond to specific targeted or immunotherapies, as shown on NIH RePORTER.
Do NSCLC clinical trials cost money to participate?
Typically, study-related medical care and investigational drugs in clinical trials are provided at no cost to participants. However, standard medical care costs may still apply, and patients should confirm coverage with the study team, according to ClinicalTrials.gov.
What are common reasons someone might not be eligible for an NSCLC trial?
Common exclusion criteria for NSCLC trials include certain co-existing medical conditions, prior specific treatments, or active brain metastases. These factors help ensure patient safety and study integrity, as detailed on ClinicalTrials.gov.
What are the potential benefits and risks of joining an NSCLC trial?
Potential benefits include access to new treatments before they are widely available and contributing to medical knowledge. Risks can include unexpected side effects or that the treatment may not be effective, as outlined on ClinicalTrials.gov.
How to find a nsclc trial that fits you
- Describe your nsclc situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.